Comparing two methods of tracheostomy in critically ill patients
Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
This study is trying to see if one type of tracheostomy procedure is safer and has fewer complications than another for critically ill patients in the Neurointensive Care Unit.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 383 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rigshospitalet, Denmark Academic / other |
| Locations | 1 site (Copenhagen) |
| Trial ID | NCT06018220 on ClinicalTrials.gov |
What this trial studies
This observational study examines the relationship between the choice of tracheostomy procedure—percutaneous dilatational tracheostomy (PDT) versus surgical tracheostomy (ST)—and the occurrence of complications in neurocritically ill patients. It focuses on patients over 18 years old admitted to the Neurointensive Care Unit at Rigshospitalet, Copenhagen, from January 2018 to December 2022. The study will analyze factors such as clinician skill level, time from admission to tracheostomy, length of hospital stay, and time to decannulation. By comparing these two methods, the study aims to provide insights into the safety and efficacy of each approach in this vulnerable patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who are admitted to the Neurointensive Care Unit and require a tracheostomy.
Not a fit: Patients under 18 years old will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could help identify the safer tracheostomy method for neurocritically ill patients, potentially reducing complications.
How similar studies have performed: Previous systematic reviews have shown no significant difference in severe complications between PDT and ST, indicating that this study builds on existing knowledge rather than exploring a completely novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients admitted to Neurointensive Care Unit, Rigshospitalet, Denmark AND having a tracheostomy performed during their stay. - Exclusion Criteria: Children - age \< 18.
Where this trial is running
Copenhagen
- Rigshospitalet — Copenhagen, Denmark (Recruiting)
Study contacts
- Study coordinator: Martin K soerensen, PHD
- Email: Martin.Kryspin.Soerensen.01@regionh.dk
- Phone: +45 35457009
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.